BRAF and melanoma: Vemurafenib, a BRAF-inhibitor, clinically used in melanoma treatment41,42, was applied systemically to BRAFWT (mOS-REpA11), BRAFV600E (mOS-REpSK-MEL-28) and non-melanoma skin equivalents (Fig. 5).